Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation
Dual induction with low doses of rabbit anti-human thymoglobulin (RATG) and basiliximab effectively and safely prevented allograft rejection in high-risk renal transplant recipients. To assess whether treatment timing affects efficacy and tolerability, in this single-center, matched-cohort study, we...
Saved in:
| Main Authors: | Alessia Gennarini, Paolo Cravedi, Maddalena Marasà, Annalisa Perna, Giovanni Rota, Mario Bontempelli, Silvio Sandrini, Giuseppe Remuzzi, Piero Ruggenenti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Journal of Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2012/426042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peculiarities of the induction immunosuppressive therapy in renal transplantation
by: O. S. Voroniak, et al.
Published: (2022-12-01) -
Roxadustat: More Than an Erythropoietic Agent?
by: Andrea Angeletti, et al.
Published: (2025-01-01) -
Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management
by: Renata Zajączkowska, et al.
Published: (2018-01-01) -
Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01) -
Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)